NCT07154797View on ClinicalTrials.gov

Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions
CataractOcular HypertensionGlaucoma
Interventions
COMBINATION_PRODUCT

Bimatoprost Implant System / IOL Combination

Bimatoprost Implant System used in combination with the SpyGlass intraocular lens

Trial Locations (1)

41101

Centro Oftalmológico Robles, Santa Rosa de Copán

All Listed Sponsors
lead

SpyGlass Pharma, Inc.

INDUSTRY